Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Daar

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|May 2, 2012
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavirGrace A McComsey, Douglas Kitch, Eric S Daar, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|December 18, 2018
Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling WeightsAshley L Buchanan, Michael G Hudgens, Stephen R Cole, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2018
Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral TherapyTodd Hulgan, Benjamin S Ramsey, John R Koethe, et al.
The Journal of Infectious Diseases|August 22, 2013
Virologic correlates of anti-CMV IgG levels in HIV-1-infected menSara Gianella, Sheldon R Morris, Erick Tatro, et al.
Emerging Infectious Diseases|November 21, 2018
Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men<sup>1</sup>Martin Hoenigl, Sonia Jain, David Moore, et al.
AIDS Research and Human Retroviruses|June 11, 2014
Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencingLaith Q Al-Mawsawi, Nicholas C Wu, Justin De La Cruz, et al.
Pharmacogenetics and Genomics|December 3, 2014
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocolsDavid S Lehmann, Heather J Ribaudo, Eric S Daar, et al.
Journal of Comparative Effectiveness Research|April 1, 2015
A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimensKristine R Broglio, Eric S Daar, Melanie Quintana, et al.
Plos Genetics|April 26, 2021
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adultsBinglan Li, Yogasudha Veturi, Anurag Verma, et al.
The Journal of Infectious Diseases|December 4, 2012
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202Grace A McComsey, Eric S Daar, MaryAnn O'Riordan, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|May 2, 2012
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavirGrace A McComsey, Douglas Kitch, Eric S Daar, et al.
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|December 18, 2018
Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling WeightsAshley L Buchanan, Michael G Hudgens, Stephen R Cole, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 12, 2018
Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral TherapyTodd Hulgan, Benjamin S Ramsey, John R Koethe, et al.
The Journal of Infectious Diseases|August 22, 2013
Virologic correlates of anti-CMV IgG levels in HIV-1-infected menSara Gianella, Sheldon R Morris, Erick Tatro, et al.
Emerging Infectious Diseases|November 21, 2018
Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men<sup>1</sup>Martin Hoenigl, Sonia Jain, David Moore, et al.
AIDS Research and Human Retroviruses|June 11, 2014
Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencingLaith Q Al-Mawsawi, Nicholas C Wu, Justin De La Cruz, et al.
Pharmacogenetics and Genomics|December 3, 2014
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocolsDavid S Lehmann, Heather J Ribaudo, Eric S Daar, et al.
Journal of Comparative Effectiveness Research|April 1, 2015
A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimensKristine R Broglio, Eric S Daar, Melanie Quintana, et al.
Plos Genetics|April 26, 2021
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adultsBinglan Li, Yogasudha Veturi, Anurag Verma, et al.
The Journal of Infectious Diseases|December 4, 2012
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202Grace A McComsey, Eric S Daar, MaryAnn O'Riordan, et al.
Pageof 23